NDC 17856-1122-01 - MAX relief junior Grape
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 17856-1122
- Requested NDC
- 17856-1122-01
- Package NDCs from labels
- 17856-1122-5, 17856-1122-1, 17856-1122-8, 17856-1122-4, 17856-1122-6, 17856-1122-2, 17856-1122-7, 17856-1122-3, 17856-1122-9, 17856-1122-01
- Manufacturer
- ATLANTIC BIOLOGICALS CORP.
- Effective date
- 2026-02-13
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| MAX relief junior Grape - ATLANTIC BIOLOGICALS CORP. | ATLANTIC BIOLOGICALS CORP. | 2026-02-13 | HUMAN OTC DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 17856-1122-1 | MAX relief junior Grape | 50 in 1 BOX, UNIT-DOSE | LIQUID | 50 | 4 | |
| 17856-1122-2 | MAX relief junior Grape | 120 in 1 BOX, UNIT-DOSE | LIQUID | 120 | 4 | |
| 17856-1122-3 | MAX relief junior Grape | 120 in 1 BOX, UNIT-DOSE | LIQUID | 120 | 4 | |
| 17856-1122-4 | MAX relief junior Grape | 72 in 1 BOX, UNIT-DOSE | LIQUID | 72 | 4 | |
| 17856-1122-5 | MAX relief junior Grape | 20.3 mL in 1 CUP, UNIT-DOSE | LIQUID | 20.3 | 4 | |
| 17856-1122-6 | MAX relief junior Grape | 1.25 mL in 1 SYRINGE | LIQUID | 1.25 | 4 | |
| 17856-1122-7 | MAX relief junior Grape | 2.5 mL in 1 SYRINGE | LIQUID | 2.5 | 4 | |
| 17856-1122-8 | MAX relief junior Grape | 15 mL in 1 CUP, UNIT-DOSE | LIQUID | 15 | 4 | |
| 17856-1122-9 | MAX relief junior Grape | 60 in 1 BOX, UNIT-DOSE | LIQUID | 60 | 4 | |
| 17856-1122-9 | MAX relief junior Grape | 1 mL in 1 SYRINGE | LIQUID | 1 | 4 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 17856-1122 | MAX RELIEF JUNIOR GRAPE (CHILDRENS ACETAMINOPHEN) LIQUID [ATLANTIC BIOLOGICALS CORP.] | 3 | Current NDC, 10 package rows | 20250514_562d7901-44d6-4d9b-be8b-a8d468a22c43.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 17856-1122-1 | ML - Milliliter | 17856-1122 | 6ff0a9b2-03be-4ea1-8611-39fbd5be4f4b | 1 | 2026-02-05 |
| 17856-1122-5 | ML - Milliliter | 17856-1122 | 8df3891c-73a2-47c4-bcee-72eea1317e38 | 1 | 2026-03-17 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Theraflu Severe Cold Relief Daytime | ACETAMINOPHEN, DEXTROMETHORPHAN HBR | Haleon US Holdings LLC | 2b962d87-6ff5-4c0f-8504-e5b61c940612 | 2025-05-05 | Warnings | 362O9ITL9D |
| 8hr arthritis pain relief | ACETAMINOPHEN | Major Pharmaceuticals | 31b3aaa2-8af2-670a-e063-6394a90a8003 | 2025-05-03 | Warnings | 362O9ITL9D |
| Cough and Sore Throat | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE LIQUID | CVS | 2d13564a-e8d1-c357-e063-6394a90ad90e | 2025-05-02 | Warnings | 362O9ITL9D |
| ACETAMINOPHEN | ACETAMINOPHEN | AARNA USA INC. | 34157f6a-3031-4388-e063-6394a90a670f | 2025-05-01 | Warnings | M013 362O9ITL9D |
| ASPIRIN | ASPIRIN | HF Acquisition Co LLC, DBA HealthFirst | 2553d0cb-3f5c-7ea0-e063-6294a90a3cd4 | 2025-05-01 | Warnings, Adverse reactions | M013 |
| Aspirin 81mg Enteric Coated | ASPIRIN | Advanced Rx LLC | 606067bb-b07f-444e-9465-d1e187735f3a | 2025-05-01 | Warnings | M013 |
| ACETAMINOPHEN AND CODEINE | ACETAMINOPHEN AND CODEINE | Direct_Rx | 8d7ca633-4448-3507-e053-2a95a90a1287 | 2025-04-29 | Boxed warning, Warnings, Adverse reactions | 362O9ITL9D |
| ACETAMINOPHEN | ACETAMINOPHEN | AARNA USA INC. | 33f0e822-28af-9bb2-e063-6294a90a5175 | 2025-04-29 | Warnings | M013 362O9ITL9D |
| ThroatSpray | ECHINACEA (ANGUSTIFOLIA), EUGENIA CARYOPHYLLATA, GLYCERINUM, MYRRHA, SALVIA OFFICINALIS, SPILANTHES OLERACEA, THYMUS SERPYLLUM, BAPTISIA TINCTORIA, PHYTOLACCA DECANDRA, HYDRASTIS CANADENSIS, APIS MELLIFICA, BELLADONNA, LACHESIS MUTUS, MERCURIUS SOLUBILIS, HEPAR SULPHURIS CALCAREUM | Energique, Inc. | 125ffbf4-681e-451c-a96d-0b6416619474 | 2025-04-29 | Warnings | PDC6A3C0OX |
| 8 HR MUSCLE ACHES AND PAIN | ACETAMINOPHEN | CVS Pharmacy | 2eb6fc42-6ba4-8f58-e063-6294a90ac6a0 | 2025-04-28 | Warnings | 362O9ITL9D |
| Tricitrates | TRICITRATES | Chartwell RX, LLC | 2a80ea6b-6334-4c33-a35e-a5cb2939fbcb | 2025-04-28 | Warnings, Adverse reactions | 1Q73Q2JULR |
| NIGHTTIME COLD AND FLU RELIEF | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE AND DOXYLAMINE SUCCINATE | Aurohealth LLC | 70e1bd25-c32e-491f-b383-91d6f74957a0 | 2025-04-28 | Warnings | 362O9ITL9D |
| Hydrocodone Bitartrate and Acetaminophen | HYDROCODONE BITARTRATE AND ACETAMINOPHEN | Asclemed USA, Inc. | ba7d27eb-952d-4e99-95b9-5b0b2f85794b | 2025-04-24 | Boxed warning, Warnings, Adverse reactions | 362O9ITL9D |
| Extra Strength Acetaminophen | ACETAMINOPHEN | Geri-Care Pharmaceutical Corp | 27fcca07-f845-77fe-e063-6394a90aa2f8 | 2025-04-24 | Warnings | M013 362O9ITL9D |
| acetaminophen | ACETAMINOPHEN | A-S Medication Solutions | 46a6bbb9-ccd1-47a8-9e58-485f71f57063 | 2025-04-24 | Warnings | M013 362O9ITL9D |
| Acetaminophen | ACETAMINOPHEN | A-S Medication Solutions | 061c91d5-5aa8-4556-a344-197b7e8a10b8 | 2025-04-24 | Warnings | M013 362O9ITL9D |
| Acetaminophen | ACETAMINOPHEN | A-S Medication Solutions | c4f0f591-8501-4c6d-bf8e-ca3068ff65b5 | 2025-04-24 | Warnings | M013 362O9ITL9D |
| Extra Strength No-Pain | ACETAMINOPHEN | Safrel Pharmaceuticals, LLC. | 873f01dd-0701-5fd3-e053-2a95a90a6463 | 2025-04-23 | Warnings | M013 362O9ITL9D |
| Sodium Citrate and Citric Acid | SODIUM CITRATE AND CITRIC ACID | Kesin Pharma Corporation | 3140f8fe-0644-7561-e063-6394a90a2c28 | 2025-04-21 | Adverse reactions | 1Q73Q2JULR XF417D3PSL |
| ADVIL DUAL ACTION WITH ACETAMINOPHEN | IBUPROFEN, ACETAMINOPHEN | Haleon US Holdings LLC | f5ea858e-76d9-4777-b3dc-5d614f66d485 | 2025-04-21 | Warnings | 362O9ITL9D |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.